A BILL
To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.


Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,


SECTION 1. Establishment of drug adherence guidelines.


Title XVII of the Public Health Service Act (42 U.S.C. 300u et seq.) is amended by inserting after section 1711 (42 U.S.C. 300u–16) the following:


“SEC. 1712. Establishment of drug adherence guidelines.


“(a) In general.—The Secretary shall establish drug adherence guidelines with the goal of achieving 90 percent adherence for all Medicare part B and D drugs.


“(b) Contents.—In establishing the guidelines under subsection (a), the Secretary shall—


“(1) incorporate artificial intelligence and machine learning technologies; and


“(2) to the maximum extent practicable, promote the use of generic and biosimilar drugs.


“(c) Definitions.—In this section:


“(1) MEDICARE PART B DRUG.—The term ‘Medicare part B drug’ means a drug or biological product for which payment may be made under part B of title XVIII of the Social Security Act (42 U.S.C. 1395j et seq.).


“(2) MEDICARE PART D DRUG.—The term ‘Medicare part D drug’ means a covered part D drug (as defined in section 1860D–2(e) of the Social Security Act (42 U.S.C. 1395w–102(e))).”.